- Lobbying
- Emily AND Casey
Lobbying Arrangements Results for 'Emily Casey'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to Medicare coverage and reimbursement and Medicaid coverage and reimbursement |
University of Colorado Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Legislation related to antimicrobial resistance(AMR), reimbursement reform, the PASTEUR Act, Cares Act 2.0 and FY24 Appropriations and PAHPA. |
The Conafay Group on behalf of Antibiotics Working Group
|
The Conafay Group, L.L.C. | |||
Details Issues related to market access. |
Advanced Drainage Systems
|
AKIN GUMP STRAUSS HAUER & FELD | |||
Details Issues related to diagnostic tests. |
SOLVD Health
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Monitor trade policy impacting sugar inputs and U.S. tariff policy. Monitor congressional developments related to the reauthorization of the farm bill. Educate policymakers on the impacts of the s... |
National Confectioners Association
|
Invariant LLC | |||
Details Visa Processing Improvement Act (S.2632) Visitor Visa Wait Time Reduction Act (H.R.5127) International travel issues International visa processing issues/ appropriations Pandemic risk insurance iss... |
Exhibitions & Conferences Alliance
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Monitor issues of importance to the U.S. agriculture and food supply chain. Analyze the impact that funding contained in P.L.117-169, the Inflation Reduction Act for climate-smart agriculture, cons... |
McDonald's Corporation
|
Invariant LLC | |||
Details issues related to microbiome, oncology, fertility, and health equity Issues related to formulary tier status NDAA FY24 |
Ferring Pharmaceuticals Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to the development and approval of therapies for rare diseases |
Harmony Biosciences
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to international vaccine deployment |
ModernaTX, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases 340B Drug Discount Program Supply chain issues affecting pharmaceutic... |
Novartis
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Monitor organic agriculture issues, including integrity and enforcement standards for organic livestock and dairy. Monitor issues related to dairy policy, including federal milk marketing order. En... |
Danone North America Public Benefit Corporation
|
Invariant LLC | |||
Details Issues related to diagnostic testing and reimbursement related to COVID testing Issues related to the Strategic National Stockpile, supply chain, and future pandemic preparedness PREVENT Pandemics... |
Cepheid
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Monitor international trade proposals and their impact on U.S. pork production. Educate Members and the Administration about the pork supply chain and monitor the impact of P.L.117-216; advocate fo... |
National Pork Producers Council
|
Invariant LLC | |||
Details Educate Members of Congress about the importance of the food and beverage industry to the U.S. economy. Monitor the outcomes of the White House Conference on Hunger, Nutrition, and Health with rega... |
PepsiCo, Inc.
|
Invariant LLC | |||
Details Issues related to scientific, technical, and medical publications Open access language in all appropriations and authorization bills Privacy Issues American Data Privacy and Pr... |
RELX Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details Safe Skies Act - Oppose unnecessary and harmful amendments to apply flight and duty rules to cargo pilots. Support efforts to ensure timely certification of electric vertical takeoff and landing... |
UPS (UNITED PARCEL SERVICE)
|
in-house lobbying | |||
Details Contacts in support of retaining all current pro-life appropriations riders and maintaining funding levels of certain riders in FY24 appropriations. Contacts in support of new riders including thos... |
NATIONAL RIGHT TO LIFE COMMITTEE
|
in-house lobbying |